金振口服液联合乙酰半胱氨酸治疗支原体肺炎的疗效及对患儿血清CYTL1、sB7-H3 水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:

2023年度南阳市科技发展计划项目(24KJGG183)


Clinical Efficacy of Jinzhen Oral Liquid Combined with Acetylcysteine for Mycoplasma pneumoniae Pneumonia and Its Effect on Serum Levels of CYTL1 and sB7-H3 in Children
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察金振口服液联合乙酰半胱氨酸治疗支原体肺炎(MPP) 的疗效及对患儿血清细胞因子样蛋白1(CYTL1)、可溶性B7同源体3(sB7-H3) 水平的影响。方法:选取2023年3月—2025年3月南阳市中心医院收治的120例MPP患儿,按随机数字表法分为对照组及联合组各60例。对照组给予乙酰半胱氨酸治疗,联合组给予金振口服液联合乙酰半胱氨酸治疗。比较2组临床疗效、症状消退时间及不良反应发生率,比较2组治疗前后免疫功能、血清CYTL1、sB7-H3、超敏C-反应蛋白(hs-CRP) 水平的变化。结果:联合组临床疗效总有效率为93.33%(56/60),对照组为78.33%(47/60),2组比较,差异有统计学意义(P<0.05)。联合组发热、咳嗽、啰音、喘息的症状消退时间均早于对照组,差异均有统计学意义(P<0.05)。治疗后,2组免疫球蛋白M(IgM)、免疫球蛋白G(IgG) 水平均较治疗前下降(P<0.05),CD3+、CD4+水平均较治疗前上升(P<0.05);联合组IgM、IgG水平均低于对照组(P<0.05),CD3+、CD4+水平均高于对照组(P<0.05)。治疗后,2 组CYTL1、sB7-H3、hs-CRP 水平均较治疗前下降(P<0.05),联合组上述3 项水平均低于对照组(P<0.05)。对照组不良反应发生率为16.67%(10/60),联合组为25.00%(15/60),2组比较,差异无统计学意义(P>0.05)。结论:金振口服液联合乙酰半胱氨酸治疗MPP疗效较好,能加快缓解症状,提升患儿的免疫功能,降低血清CYTL1、sB7-H3、hs-CRP水平,减轻炎症反应,安全性高。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of Jinzhen Oral Liquid combined with Acetylcysteine in the treatment of Mycoplasma pneumoniae pneumonia (MPP) and its effect on serum levels of cytokine-like protein 1 (CYTL1) and soluble B7 homolog 3 (sB7-H3) in children. Methods:A total of 120 children with MPP admitted to Nanyang Central Hospital from March 2023 to March 2025 were selected and divided into the control group and the combination group according to the random number table method,with 60 cases in each group. The control group was treated with Acetylcysteine, and the combination group was treated with Jinzhen Oral Liquid combined with Acetylcysteine. The clinical efficacy, symptom resolution time, and incidence of adverse reactions were compared between the two groups. The changes in immune function,serum levels of CYTL1,sB7-H3,and high-sensitivity C-reactive protein (hs-CRP) before and after treatment were also compared between the two groups. Results:The total clinical effective rate was 93.33% (56/60) in the combination group and 78.33% (47/60) in the control group, the difference being significant (P<0.05). The resolution time of fever,cough,rales,and wheezing in the combination group was earlier than that in the control group,differences being significant (P<0.05). After treatment,the levels of immunoglobulin M (IgM) and immunoglobulin G (IgG) in both groups were decreased when compared with those before treatment (P<0.05),while the levels of CD3+ and CD4+ were increased (P<0.05);the levels of IgM and IgG in the combination group were lower than those in the control group (P<0.05),and the levels of CD3+ and CD4+ were higher than those in the control group (P<0.05). After treatment, the levels of CYTL1, sB7-H3, and hs-CRP in both groups were decreased when compared with those before treatment (P<0.05), and the levels of the above three indicators in the combination group were lower than those in the control group (P<0.05). The incidence of adverse reactions was 16.67% (10/60) in the control group and 25.00% (15/60) in the combination group, there being no significant difference between the two groups (P>0.05). Conclusion: Jinzhen Oral Liquid combined with Acetylcysteine is effective in treating MPP. It can accelerate the relief of symptoms, improve the immune function of children,reduce the serum levels of CYTL1,sB7-H3,and hs-CRP,alleviate inflammatory response,and has high safety.

    参考文献
    相似文献
    引证文献
引用本文

张贵春,吴琼,李正一,杨静.金振口服液联合乙酰半胱氨酸治疗支原体肺炎的疗效及对患儿血清CYTL1、sB7-H3 水平的影响[J].新中医,2026,58(19):43-47

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-10-16
  • 出版日期:
文章二维码